DE2709500C2 - Verfahren zur Reinigung von Heparin - Google Patents
Verfahren zur Reinigung von HeparinInfo
- Publication number
- DE2709500C2 DE2709500C2 DE2709500A DE2709500A DE2709500C2 DE 2709500 C2 DE2709500 C2 DE 2709500C2 DE 2709500 A DE2709500 A DE 2709500A DE 2709500 A DE2709500 A DE 2709500A DE 2709500 C2 DE2709500 C2 DE 2709500C2
- Authority
- DE
- Germany
- Prior art keywords
- heparin
- gel
- matrix
- antithrombin
- bound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920000669 heparin Polymers 0.000 title claims description 40
- 229960002897 heparin Drugs 0.000 title claims description 40
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title claims description 39
- 238000000034 method Methods 0.000 title claims description 13
- 239000011159 matrix material Substances 0.000 claims description 12
- 239000004019 antithrombin Substances 0.000 claims description 11
- 229940122618 Trypsin inhibitor Drugs 0.000 claims description 4
- 239000002753 trypsin inhibitor Substances 0.000 claims description 4
- 229920000936 Agarose Polymers 0.000 claims description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- 230000000694 effects Effects 0.000 description 14
- 239000000872 buffer Substances 0.000 description 10
- 239000007983 Tris buffer Substances 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 8
- 238000000746 purification Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 4
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- 102000013831 Coagulation factor IX Human genes 0.000 description 2
- 108010076282 Factor IX Proteins 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 229940105774 coagulation factor ix Drugs 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 102100030009 Azurocidin Human genes 0.000 description 1
- 101710154607 Azurocidin Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000012511 carbohydrate analysis Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7603040A SE431218B (sv) | 1976-03-05 | 1976-03-05 | Forfarande for rening av heparin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2709500A1 DE2709500A1 (de) | 1977-09-08 |
| DE2709500C2 true DE2709500C2 (de) | 1986-09-18 |
Family
ID=20327240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2709500A Expired DE2709500C2 (de) | 1976-03-05 | 1977-03-04 | Verfahren zur Reinigung von Heparin |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS52108012A (cs) |
| AT (1) | AT356818B (cs) |
| AU (1) | AU508430B2 (cs) |
| CA (1) | CA1079272A (cs) |
| CS (1) | CS196349B2 (cs) |
| DE (1) | DE2709500C2 (cs) |
| DK (1) | DK155606C (cs) |
| ES (1) | ES456196A1 (cs) |
| FI (1) | FI62103C (cs) |
| FR (1) | FR2342991A1 (cs) |
| GB (1) | GB1539332A (cs) |
| HU (1) | HU176811B (cs) |
| IE (1) | IE44907B1 (cs) |
| IL (1) | IL51346A (cs) |
| NL (1) | NL186385C (cs) |
| NO (1) | NO144388C (cs) |
| NZ (1) | NZ183480A (cs) |
| PL (1) | PL103049B1 (cs) |
| SE (1) | SE431218B (cs) |
| SU (1) | SU736860A3 (cs) |
| ZA (1) | ZA771267B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE449753B (sv) * | 1978-11-06 | 1987-05-18 | Choay Sa | Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav |
| DE3531101A1 (de) * | 1984-08-31 | 1986-03-13 | Nicolás Huberto Olivos Behrens | Ein nicht thrombenbildendes heparin und ein verfahren zu seiner gewinnung |
| US9676816B2 (en) * | 2014-01-21 | 2017-06-13 | Board Of Trustees Of The University Of Arkansas | Heparin affinity tag and applications thereof |
| CN119039480A (zh) * | 2024-11-01 | 2024-11-29 | 山东万邦赛诺康生化制药股份有限公司 | 一种肝素钠酶解精制方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2623001A (en) * | 1949-04-07 | 1952-12-23 | Bengt E G V Sylven | Preparing heparin |
| DE1195010B (de) * | 1962-05-12 | 1965-06-16 | Ormonoterapia Richter S P A | Verfahren zur Reinigung von Heparin nach der Chromatographischen Methode |
-
1976
- 1976-03-05 SE SE7603040A patent/SE431218B/xx not_active IP Right Cessation
-
1977
- 1977-01-27 IL IL51346A patent/IL51346A/xx unknown
- 1977-02-14 CA CA271,731A patent/CA1079272A/en not_active Expired
- 1977-02-15 FI FI770491A patent/FI62103C/fi not_active IP Right Cessation
- 1977-02-22 NL NLAANVRAGE7701882,A patent/NL186385C/xx not_active IP Right Cessation
- 1977-02-23 ES ES456196A patent/ES456196A1/es not_active Expired
- 1977-02-25 JP JP2016477A patent/JPS52108012A/ja active Pending
- 1977-03-02 NZ NZ183480A patent/NZ183480A/xx unknown
- 1977-03-03 IE IE469/77A patent/IE44907B1/en not_active IP Right Cessation
- 1977-03-03 ZA ZA00771267A patent/ZA771267B/xx unknown
- 1977-03-04 SU SU772457090A patent/SU736860A3/ru active
- 1977-03-04 HU HU77KA1485A patent/HU176811B/hu unknown
- 1977-03-04 GB GB9275/77A patent/GB1539332A/en not_active Expired
- 1977-03-04 FR FR7706469A patent/FR2342991A1/fr active Granted
- 1977-03-04 AU AU22953/77A patent/AU508430B2/en not_active Expired
- 1977-03-04 DK DK096077A patent/DK155606C/da not_active IP Right Cessation
- 1977-03-04 AT AT144577A patent/AT356818B/de not_active IP Right Cessation
- 1977-03-04 NO NO770764A patent/NO144388C/no unknown
- 1977-03-04 PL PL1977196438A patent/PL103049B1/pl unknown
- 1977-03-04 DE DE2709500A patent/DE2709500C2/de not_active Expired
- 1977-03-07 CS CS771523A patent/CS196349B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2709500A1 (de) | 1977-09-08 |
| ATA144577A (de) | 1979-10-15 |
| NO144388C (no) | 1981-08-19 |
| IE44907L (en) | 1977-09-05 |
| FR2342991B1 (cs) | 1981-10-30 |
| NL7701882A (nl) | 1977-09-07 |
| GB1539332A (en) | 1979-01-31 |
| HU176811B (en) | 1981-05-28 |
| DK155606C (da) | 1989-09-11 |
| FI62103C (fi) | 1982-11-10 |
| IL51346A0 (en) | 1977-03-31 |
| JPS52108012A (en) | 1977-09-10 |
| ZA771267B (en) | 1978-01-25 |
| NO770764L (no) | 1977-09-06 |
| NZ183480A (en) | 1979-08-31 |
| ES456196A1 (es) | 1978-07-01 |
| NL186385B (nl) | 1990-06-18 |
| AU2295377A (en) | 1978-09-07 |
| AT356818B (de) | 1980-05-27 |
| DK96077A (da) | 1977-09-06 |
| IE44907B1 (en) | 1982-05-19 |
| AU508430B2 (en) | 1980-03-20 |
| DK155606B (da) | 1989-04-24 |
| PL103049B1 (pl) | 1979-05-31 |
| NO144388B (no) | 1981-05-11 |
| CS196349B2 (en) | 1980-03-31 |
| NL186385C (nl) | 1990-11-16 |
| CA1079272A (en) | 1980-06-10 |
| FR2342991A1 (fr) | 1977-09-30 |
| SE431218B (sv) | 1984-01-23 |
| IL51346A (en) | 1979-11-30 |
| FI62103B (fi) | 1982-07-30 |
| FI770491A7 (cs) | 1977-09-06 |
| SU736860A3 (ru) | 1980-05-25 |
| SE7603040L (sv) | 1977-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2417619C2 (de) | Intramolekular vernetztes Hämoglobin, Verfahren zu dessen Herstellung und seine Verwendung | |
| DE2839170C2 (de) | Chromatographisches Material | |
| DE2322552C2 (de) | Verfahren zum Abtrennen von Protein A aus Staphylococcus aureus aus einer Flüssigkeit | |
| DE3346336C2 (cs) | ||
| DE2243688A1 (de) | Verfahren zur isolierung von antithrombin aus tierischem material durch adsorption an sulfatisierte kohlenhydrate | |
| DE69002427T2 (de) | Verfahren zur Herstellung eines Konzentrats des Faktor VIII-von Willebrand-Faktor-Komplexes der Blutgerinnung aus Vollplasma. | |
| EP0409053B1 (de) | Verfahren zur Reinigung von Annexinen | |
| EP1005492A1 (de) | Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie | |
| DE2711773A1 (de) | Verfahren zur reinigung und isolierung von hepatitisvirus zur herstellung eines impfstoffes | |
| DE69125764T2 (de) | Verfahren zur Herstellung des Von Willebrand-Faktors von höchster Reinheit | |
| CH647158A5 (de) | Verfahren zur reinigung von interferon. | |
| DE1054405B (de) | Verfahren zur Gewinnung von Urokinasekonzentraten | |
| EP0307002B1 (de) | Verfahren zur Herstellung eines Antithrombin III-Konzentrates | |
| EP0457371A1 (de) | Verfahren zur Gewinnung des Gewebeproteins PP4 | |
| DE68908426T2 (de) | Adjuvanz für Krebsimmuntherapie. | |
| EP1326893A2 (de) | Bikunin enthaltende plasmafraktion, verfahren zu ihrer herstellung und ihrer verwendung | |
| DE3787996T2 (de) | Heparine, frei von E.D.T.A., Fraktionen und Fragmente von Heparin, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, welche diese enthalten. | |
| DE2709500C2 (de) | Verfahren zur Reinigung von Heparin | |
| DE2551966C3 (de) | Verfahren zum Reinigen von Urokinase | |
| EP0049861B1 (de) | Thrombininhibitor, seine Herstellung und Verwendung | |
| DE3724726A1 (de) | Verfahren zur reinigung des plazentaren gewebeproteins pp4 | |
| DE1642676A1 (de) | Verfahren zur Reinigung von Lipopolysacchariden | |
| CH643861A5 (de) | Verfahren zum reinigen eines gamma-globulinderivats. | |
| DE2448371A1 (de) | Verfahren zur isolierung der transferrine aus biologischen stoffen | |
| DE2428955C3 (de) | Verfahren zur Abtrennung der enzymatischen Komponente mit in vivo antikoagulierender und in vitro koagulierender Wirkung aus dem Gift der Schlange Ancistrodon rhodostoma und daraus hergestellte Mittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: KABI PHARMACIA AB, UPPSALA, SE |
|
| 8328 | Change in the person/name/address of the agent |
Free format text: FRHR. VON PECHMANN, E., DIPL.-CHEM. DR.RER.NAT. BEHRENS, D., DR.-ING. GOETZ, R., DIPL.-ING. DIPL.-WIRTSCH.-ING., PAT.-ANWAELTE, 8000 MUENCHEN |